Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06367374
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-03-20
Brief Title:
MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLLSLL
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China
Organization Data
Organization:
Institute of Hematology Blood Diseases Hospital China
Class:
OTHER
Study ID:
BGB-11417-2002-IITBDH-CLL-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Hematology Blood Diseases Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
Qiu Lugui
Responsible Party Title:
Institute of Hematology Blood Diseases Hospital China
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Institute of Hematology Blood Diseases Hospital China
Old Name:
None
Old Organization:
None